Literature DB >> 12183534

Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.

Denis Martin1, Stéphane Rioux, Edith Gagnon, Martine Boyer, Josée Hamel, Nathalie Charland, Bernard R Brodeur.   

Abstract

The protective potential of antibodies directed against group B streptococcus (GBS) Sip surface protein was determined by using the mouse neonatal infection model. Rabbit Sip-specific antibodies administered passively to pregnant mice protected their pups against a GBS lethal challenge. In addition, active immunization with purified recombinant Sip protein of female CD-1 mice induced the production of specific antibodies that also confer protection to the newborn pups against GBS strains of serotypes Ia/c, Ib, II, III, and V. These data confirm that Sip-specific antibodies can cross the placenta and conferred protective immunity against GBS infections.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12183534      PMCID： PMC128249          DOI： 10.1128/IAI.70.9.4897-4901.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  31 in total

1.  Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.

Authors:  L C Paoletti; D L Kasper; F Michon; J DiFabio; H J Jennings; T D Tosteson; M R Wessels
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

Authors:  C J Baker; M A Rench; M S Edwards; R J Carpenter; B M Hays; D L Kasper
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

Review 5.  Group B streptococcal vaccines.

Authors:  C J Baker; D L Kasper
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

6.  Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; A K Rodewald; A A Shroff; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  M R Wessels; L C Paoletti; A K Rodewald; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

Authors:  L C Madoff; L C Paoletti; J Y Tai; D L Kasper
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Neonatal mouse model of group B streptococcal infection.

Authors:  A K Rodewald; A B Onderdonk; H B Warren; D L Kasper
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Immunodeterminant specificity of human immunity to type III group B streptococcus.

Authors:  D L Kasper; C J Baker; R S Baltimore; J H Crabb; G Schiffman; H J Jennings
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307
View more
  18 in total

1.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Authors:  Francesco Doro; Sabrina Liberatori; Manuel J Rodríguez-Ortega; Cira D Rinaudo; Roberto Rosini; Marirosa Mora; Maria Scarselli; Emrah Altindis; Romina D'Aurizio; Maria Stella; Immaculada Margarit; Domenico Maione; John L Telford; Nathalie Norais; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2009-04-28       Impact factor: 5.911

Review 3.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.

Authors:  Sarah E Clark; Rebecca L Schmidt; Elizabeth R Aguilera; Laurel L Lenz
Journal:  Transl Res       Date:  2020-07-04       Impact factor: 7.012

Review 5.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.

Authors:  Jacqueline A Baker; Emma L Lewis; Leah M Byland; Maryam Bonakdar; Tara M Randis; Adam J Ratner
Journal:  Vaccine       Date:  2017-02-02       Impact factor: 3.641

7.  Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge.

Authors:  Sukumar Pal; Olga Tatarenkova; Luis M de la Maza
Journal:  J Reprod Immunol       Date:  2010-06-15       Impact factor: 4.054

8.  Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.

Authors:  Haiyang Xu; Changmin Hu; Rui Gong; Yingyu Chen; Ningning Ren; Ganwen Xiao; Qian Xie; Minmin Zhang; Qin Liu; Aizhen Guo; Huanchun Chen
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

9.  Identification and immunoreactivity of proteins released from Streptococcus agalactiae.

Authors:  K Fluegge; O Schweier; E Schiltz; S Batsford; R Berner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-14       Impact factor: 3.267

10.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.